China Resources Pharmaceutical Group (3320.HK) Earnings Analysis
China Resources Pharmaceutical Group (3320.HK) next reports earnings on 2026-08-25, consensus EPS 0.4618 HKD. Last quarter (2026-03-24) it beat with EPS 0.345 HKD vs 0.2226 HKD est (+55%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 6.85.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 3320.HK next report earnings?
| Next earnings date | 2026-08-25 |
|---|---|
| Consensus EPS estimate | 0.4618 HKD |
| Revenue estimate | 159.99B |
3320.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-24 | 0.345 HKD | 0.2226 HKD | +55% | Beat |
| 2025-08-26 | 0.3623 HKD | 0.4195 HKD | -13.6% | Miss |
| 2024-10-24 | 0.4493 HKD | 0.4605 HKD | -2.4% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
3320.HK valuation and analyst view
| Trailing P/E | 6.85 |
|---|---|
| Trailing EPS | 0.71118 HKD |
| Price / book | 0.53 |
| Dividend yield | 4.48% |
| Market cap | 30.03B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is China Resources Pharmaceutical Group (3320.HK)'s next earnings date?
China Resources Pharmaceutical Group is next scheduled to report on 2026-08-25, with a consensus EPS estimate of 0.4618 HKD and revenue estimate of 159.99B.
Did 3320.HK beat earnings last quarter?
In its 2026-03-24 report, 3320.HK posted EPS of 0.345 HKD versus a 0.2226 HKD estimate — a beat of 55%.
What is 3320.HK's earnings track record?
Over the last 3 reported quarters with consensus data, 3320.HK beat estimates 1 times (33%).
What is 3320.HK's current P/E ratio and EPS?
3320.HK trades at a trailing P/E of 6.85 on trailing EPS of 0.711179122916265 HKD.
What do analysts rate 3320.HK?
3320.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.